(Bloomberg) -- Life sciences company Danaher Corp. has expressed takeover interest in contract manufacturer Catalent Inc., according to people familiar with the matter. Most Read from Bloomberg ...
(Bloomberg) -- Catalent Inc. shares rose after the troubled contract drug manufacturer gave investors some reassurance about a slashed fiscal full-year outlook and the third delay to its quarterly ...
When the companies first unveiled their takeover plans, Novo Holdings and Catalent said ... Bloomberg reported back in February of 2023 that life sciences conglomerate Danaher had expressed an ...
April 24, 2024 The Takeover Trailer April 24, 2024 • The largest school district in Texas lost its elected leaders in the summer of 2023. In their place – a state-appointed board along with a ...
Pall Corp. (PLL) stock is rising after the company said it will be acquired by Danaher (DHR) for $13.8 billion. Pall Corp. (PLL) stock is rising after the company said it will be acquired by ...
Danaher stock (NYSE: DHR), a conglomerate with products in life sciences, biotechnology, and diagnostics fields, recently posted its Q1 results that exceeded the street expectations. The company ...
Catalent, Inc. is a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer ...
Diners are in for a party atmosphere at the next stop in the Detroit Free Press and Metro Detroit Chevy Dealers popular Top 10 Takeover dining series. The series is celebrating its 10th ...
WASHINGTON (AP) — WASHINGTON (AP) — Danaher Corp. (DHR) on Tuesday reported first-quarter profit of $1.09 billion. The Washington-based company said it had net income of $1.45 per share.
No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...